Asthma is characterized by allergic airway inflammation and airway remodeling which underlie the clinicalcharacteristics of airflow limitation, bronchial hyperresponsiveness, and susceptibility to exacerbation.Important questions remain for how asthma develops, the mechanisms of allergen sensitization, and thefactors that contribute to the persistence of asthmatic airway changes over a lifetime. Here we proposeclinical studies to investigate fundamental questions about the role of chitinases and TGFp in initiating andperpetuating allergic asthma. We will combine comprehensive genetic studies with detailed translationalstudies to address hypotheses for how polymorphisms in chitinase and TGFp pathway genes influenceallergen sensitization, asthma susceptibility and expression of asthma-related phenotypes.
Aim 1 willdetermine the independent and dependent effects of genetic variants in chitinases (AMCase/CHIT1) onsensitization to fungal aeroallergens and other asthma outcomes. Genetic variants in the CHIT1 andAMCase genes will be tested for association with skin test sensitivity to fungal aeroallergens and otherasthma phenotypes in a cohort of 1700 asthma cases provided by the Asthma Clinical Research Networkand independent cohorts of Latino and African American subjects.
Aim 2 will examine the autonomous andinteractive effects of genetic variants in 26 TGFp pathway genes on asthma and asthma-related phenotypesin several large, well-characterized, ethnically diverse asthma family based and case-control cohorts.Associated SNPs will be replicated in independent populations.
Aim 3 will evaluate the functionalsignificance of the genes and genetic variants examined in Aims 1 and 2. We will analyze the relative geneand protein expression of CHIT1 and AMCase in specific lung compartments and the effects of geneticvariants on expression of splice variants and levels of airway chitinase activity. We will determine if any ofthe 26 TGFp pathway genes analyzed show differential expression in the lung in asthma.
Our aims arefounded on preliminary data from human subjects and integrate closely with the scientific themes of projects1 and 2. Together, our studies will greatly advance understanding of the roles of chitinases and TGFp familymembers in allergy and asthma and could suggest novel treatment approaches.Lay summary: We will examine the effect of genetic variation in the CHIT1, AMCase and TGFp pathway onasthma and asthma related traits in ethnically diverse populations. We will also examine the effect of geneticvariation in these genes on gene and protein expression in the lungs of subjects with asthma.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI077439-01
Application #
7476191
Study Section
Special Emphasis Panel (ZAI1-QV-I (J1))
Project Start
2008-04-01
Project End
2013-03-31
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
1
Fiscal Year
2008
Total Cost
$359,434
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Bhakta, Nirav R; Christenson, Stephanie A; Nerella, Srilaxmi et al. (2018) IFN-stimulated Gene Expression, Type 2 Inflammation, and Endoplasmic Reticulum Stress in Asthma. Am J Respir Crit Care Med 197:313-324
Levin, Albert M; Gui, Hongsheng; Hernandez-Pacheco, Natalia et al. (2018) Integrative approach identifies corticosteroid response variant in diverse populations with asthma. J Allergy Clin Immunol :
Wong-McGrath, Kelly; Denlinger, Loren C; Bleecker, Eugene R et al. (2018) Internet-Based Monitoring in the Severe Asthma Research Program Identifies a Subgroup of Patients With Labile Asthma Control. Chest 153:378-386
Oh, Sam S; Du, Randal; Zeiger, Andrew M et al. (2017) Breastfeeding associated with higher lung function in African American youths with asthma. J Asthma 54:856-865
Sherenian, M G; Cho, S H; Levin, A et al. (2017) PAI-1 gain-of-function genotype, factors increasing PAI-1 levels, and airway obstruction: The GALA II Cohort. Clin Exp Allergy 47:1150-1158
Bonser, Luke R; Erle, David J (2017) Airway Mucus and Asthma: The Role of MUC5AC and MUC5B. J Clin Med 6:
Yi, L; Cheng, D; Zhang, K et al. (2017) Intelectin contributes to allergen-induced IL-25, IL-33, and TSLP expression and type 2 response in asthma and atopic dermatitis. Mucosal Immunol 10:1491-1503
Sundaram, Aparna; Chen, Chun; Khalifeh-Soltani, Amin et al. (2017) Targeting integrin ?5?1 ameliorates severe airway hyperresponsiveness in experimental asthma. J Clin Invest 127:365-374
Thakur, Neeta; Barcelo, Nicolas E; Borrell, Luisa N et al. (2017) Perceived Discrimination Associated With Asthma and Related Outcomes in Minority Youth: The GALA II and SAGE II Studies. Chest 151:804-812
Wells, Karen E; Cajigal, Sonia; Peterson, Edward L et al. (2016) Assessing differences in inhaled corticosteroid response by self-reported race-ethnicity and genetic ancestry among asthmatic subjects. J Allergy Clin Immunol 137:1364-1369.e2

Showing the most recent 10 out of 117 publications